| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Scientific Officer &COO | Chief Development Officer
2 companies
Vera Juan serves as a Chief Scientific Officer &COO at MRKR and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 25 sells. Those positions are worth an estimated $1.3M at current prices.
The biggest single holding is MRKR (~$1.3M) as Chief Scientific Officer &COO. Net of sales, the recent Form 4 record there shows accumulation of 571,428 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | Chief Development Officer | Buy | 571,428 | $1.75 | $999,999.00 | +28.7% | +91.4% | -77.7% | |
| Mar 3, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 63,836 | $38.41 | $2,451,759.67 | -2.7% | - | - | |
| Feb 23, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 36,404 | $41.51 | $1,511,309.66 | -1.5% | - | - | |
| Feb 18, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 8,942 | $40.75 | $364,368.36 | -0.4% | - | - | |
| Feb 17, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 17,860 | $41.23 | $736,294.95 | -0.7% | - | - |